After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial of Xencor Blood Cancer Antibody XmAb14045

After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial of Xencor Blood Cancer Antibody XmAb14045

Miracle Drugs Don’t Always Work— A Rare but Lethal Case of an Immuno-Oncology Backfire

Miracle Drugs Don’t Always Work— A Rare but Lethal Case of an Immuno-Oncology Backfire

CAR-T Cell Therapy | What You Need To Know

  CAR-T therapy has demonstrated promising results in a range of patients from young and old. This type of immunotherapy teaches T cells to recognize and destroy cancer. In some patients, this can lead to the total elimination of the cancer. In others, there is a significant improvement of the disease. 2017 was the first year … Συνεχίστε να διαβάζετε CAR-T Cell Therapy | What You Need To Know.

New Insights to Improve CAR T Cells’ Safety

Drugs approved to treat rheumatoid arthritis block cytokines, the molecules responsible for severe side effects from the immunotherapy, and reduce symptoms in mice. By Vicki Brower     Illustration of chimeric antigen receptors on the surface of an engineered T cellISTOCK, SELVANEGRA     Chimeric antigen receptor, or CAR, T-cell therapy has proven itself to … Συνεχίστε να διαβάζετε New Insights to Improve CAR T Cells’ Safety.